, Newburyport, MA

Local News

March 2, 2012

PCI Synthesis is part of 'new generation' at business park

EDITOR'S NOTE: This is the first of a series of articles focusing on companies in Newburyport's business park. The series intends to show the kinds of businesses, innovations and job opportunities that are emerging as the park strives to compete in the global economy.

NEWBURYPORT — The industrial park here was founded decades ago, but today, numerous companies in the current business park are focused on high-tech solutions that are filling modern technical needs of companies around the country.

One such business is PCI Synthesis, a privately held enterprise that is involved in chemical manufacturing for biotech and pharmaceutical companies.

At 9 Opportunity Way, it is currently running three shifts and is recruiting qualified technical staff all the time.

PCI Synthesis is a 12-year-old custom chemical manufacturer of new chemical entities, generic active pharmaceutical ingredients and other specialty chemical products.

A contract manufacturing organization, PCI provides emerging and midsized pharmaceutical companies access "to the expertise needed to develop and manufacture complex small molecules and APIs used in generic pharmaceuticals."

Though he is in a very competitive market, PCI President Ed Price has found a way to create and sell quality products.

"Outsourcing by pharmaceutical companies (to companies like us) has been increasing," Price said. "We can help them for an early-stage idea to commercialization.

"We're in a good position here in Newburyport, being in the backyard of Boston-Cambridge, which has many pharma and biotech firms."

PCI employs about 95 in highly technical positions. It maintains a research and development arm in Devens, which has about 33 workers.

In recent months, PCI announced a collaboration deal with Biogen Idec, a public company that started in Cambridge and is considered one of the most prominent biotech operations in the country.

Part of PCI's role with Biogen Idec is to "evaluate and optimize a number of new compounds with the goal of identifying potential new drugs."

Text Only | Photo Reprints

Port Pics
AP Video
Raw: Israel Bombs Multiple Targets in Gaza Veteran Creates Job During High Unemployment Raw: Cargo Craft Undocks From Space Station Widow: Jury Sent Big Tobacco a $23B Message New Orleans Plans to Recycle Cigarette Butts UN Security Council Calls for MH 17 Crash Probe Obama Bestows Medal of Honor on NH Veteran Texas Sending National Guard Troops to Border Hopkins to Pay $190M After Pelvic Exams Taped Foxx Cites Washington 'Circus Mirror' NASA Ceremony Honors Moon Walker Neil Armstrong Obama Voices Concern About Casualties in Mideast Diplomacy Intensifies Amid Mounting Gaza Toll AP Exclusive: American Beaten in Israel Speaks Obama Protects Gay, Transgender Workers Raw: Gaza Rescuers Search Rubble for Survivors Raw: International Team Inspects MH17 Bodies Raw: 25 Family Members Killed in Gaza Airstrike US Teen Beaten in Mideast Talks About Ordeal 'Weird Al' Is Wowed by Album's Success
Special Features